These results are remarkably similar to what we observed earlier in AD/AI LNCaP and LAPC4 systems and suggest that systemic androgen levels dynamically regulate the abundance of PSA+ vs. PSA−/lo cells in prostate tumors. This evidence concerns the gene KLK3 and prostate neoplasm.